ToFAcitinib in Early Active Axial SpondyloarThritis:
ToFAcitinib in Early Active Axial SpondyloarThritis:
Recruiting · NCT06112665 · Registry updated 2024-11-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ToFAcitinib in Early Active Axial SpondyloarThritis: | Axial Spondyloarthritis, Spondylarthritis, Spondylarthropathies, ankylosis, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, spondylitis, vertebral column disorder | Recruiting | Phase 4 | 2024-11-26 | NCT06112665 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Charite University, Berlin, Germany | 188 |
| Pfizer | 431 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Charité Universitätsmedizin Berlin | Berlin | Germany | 15 |